Testing, herd immunity and an eventual relaxation of mitigation efforts
After weeks of containment efforts, some governments dip their toe into the
uncertain waters of re-opening parts of the economy. What needs to be in place in order to get back to a certain state of normalcy? And how does testing help in this endeavour?
We attended the ASCO 2023 annual meeting in Chicago. After the rise of immuno-oncology, COVID-19 challenged clinical trial execution and muted patient numbers. In the last years we saw many setbacks of once promising immuno-oncology combinations trials.
What mattered this month in healthcare? Q1 reporting came to a close, and FTC action put pressure on the biopharma space and... Find out more in our monthly healthcare newsletter.
With M&A picking up, are we at a turning point for biotech? Check out our latest Kieger AG Chart of the Month Video.